Cargando…
Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa
INTRODUCTION: Some observational data suggest that the progestogen injectable contraceptive depot medroxyprogesterone acetate (DMPA) may increase a woman’s risk of HIV acquisition but a randomized clinical trial did not find a statistically significant increase in HIV risk for women using DMPA compa...
Autores principales: | Smith, Jennifer A, Beacroft, Leo, Abdullah, Fareed, Buthelezi, Buyile, Makua, Manala, Morroni, Chelsea, Ramjee, Gita, Velasquez, Claudia, Hallett, Timothy B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543057/ https://www.ncbi.nlm.nih.gov/pubmed/33030312 http://dx.doi.org/10.1002/jia2.25620 |
Ejemplares similares
-
What impact could DMPA use have had in South Africa and how might its continued use affect the future of the HIV epidemic?
por: Beacroft, Leo, et al.
Publicado: (2019) -
The potential impact of a “curative intervention” for HIV: a modelling study
por: Beacroft, Leo, et al.
Publicado: (2019) -
Correction to: The potential impact of a “curative intervention” for HIV: a modelling study
por: Beacroft, Leo, et al.
Publicado: (2020) -
Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial
por: Ryan, Rebecca, et al.
Publicado: (2022) -
Knowledge and use of emergency contraception among women in the Western Cape province of South Africa: a cross-sectional study
por: Myer, Landon, et al.
Publicado: (2007)